At the start of 2026, Pathomation’s team reflects on where the digital pathology market is heading.

In this video, our Project Manager, Account Manager, Business Development Manager and CEO share their perspective on:

• The evolution of digital pathology in clinical diagnostics and life sciences

• The growing role of AI and interoperability

• Changing expectations from laboratories, research institutions and industry partners

• Market maturity, regulation and global adoption trends

From workflow efficiency in routine diagnostics to scalable research environments and AI integration, this discussion highlights the opportunities and challenges that will shape the coming years.

As a vendor-agnostic, CE-IVD certified digital pathology software provider, Pathomation remains committed to building flexible, interoperable solutions that connect pixels with people.